Shannon Strenn
Physician Assistant · Atlanta, GANPI 1821729716
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 506 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 506 payments — averaging $20.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Amgen$2K
- Johnson & Johnson$1K
- UCB, Inc.$583
- AstraZeneca$579
- ANI Pharmaceuticals, Inc.$562
- plus $4K from 23 others
What the payments were for
- Food & beverage$10,10398%
- Education$1542%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 110 | $2,228 |
| Amgen | 76 | $1,628 |
| Johnson & Johnson | 47 | $1,013 |
| UCB, Inc. | 32 | $583 |
| AstraZeneca(2 entities) | 32 | $579 |
| ANI Pharmaceuticals, Inc. | 21 | $562 |
| Novartis | 36 | $503 |
| Pfizer | 21 | $423 |
| GSK | 19 | $388 |
| Lilly USA, LLC | 20 | $377 |
| Organon | 17 | $346 |
| Aurinia Pharma U.S., Inc. | 11 | $260 |
| Mallinckrodt Hospital Products Inc. | 11 | $242 |
| Sanofi | 5 | $122 |
| Sandoz | 6 | $120 |
| Radius Health, Inc. | 5 | $112 |
| Fresenius Kabi USA, LLC | 6 | $109 |
| E.r. Squibb & Sons, L.L.C. | 6 | $107 |
| Galt Pharmaceuticals, LLC | 1 | $100 |
| Kiniksa Pharmaceuticals International, PLC | 4 | $75 |
| Almatica Pharma LLC | 3 | $57 |
| Octapharma USA, Inc. | 3 | $56 |
| Scilex Pharmaceuticals Inc. | 3 | $48 |
| Boehringer Ingelheim | 2 | $47 |
| Kiniksa Pharmaceuticals, Ltd. | 3 | $45 |
| Genentech USA, Inc. | 2 | $41 |
| Kowa Pharmaceuticals America, Inc. | 2 | $38 |
| Laborie Medical Technologies Corp. | 1 | $26 |
| Boston Scientific | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,257 in reported general payments places this provider in the 95th percentile of 3,581 physician assistant providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EvoxacCevimeline Hcl | 12 | $8,408 |
| Mycophenolate Mofetil | 13 | $3,293 |
| Hydroxychloroquine Sulfate | 83 | $2,736 |
| Pilocarpine Hcl | 33 | $2,718 |
| Duloxetine Hcl | 38 | $1,630 |
| Febuxostat | 22 | $1,428 |
| Celecoxib | 35 | $1,411 |
| Prednisone | 121 | $1,032 |
| MethotrexateMethotrexate Sodium | 73 | $1,023 |
| Gabapentin | 48 | $840 |
| Leflunomide | 15 | $765 |
| Diclofenac Sodium | 19 | $501 |
| Pregabalin | 23 | $485 |
| Cyclobenzaprine Hcl | 27 | $403 |
| Tizanidine Hcl | 29 | $399 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Atlanta
- Jennifer CobbsAtlanta$1M
- Alison MoeAtlanta$410K
- Maggie SchreckAtlanta$389K
- Jaime AckermanAtlanta$84K
- Andrew GoodnerAtlanta$56K
- Tiffany LangemanAtlanta$53K
- Amy SimoneAtlanta$51K
- Rachel NeelyAtlanta$44K
- Jennifer YoungAtlanta$32K
- Kia CampbellAtlanta$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.